Back to Search
Start Over
Sustained efficacy up to 4[middle dot]5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
- Source :
- The Lancet. April 15, 2006, Vol. 367 Issue 9518, p1247, 9 p.
- Publication Year :
- 2006
Details
- Language :
- English
- ISSN :
- 01406736
- Volume :
- 367
- Issue :
- 9518
- Database :
- Gale General OneFile
- Journal :
- The Lancet
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.198164995